Your browser doesn't support javascript.
loading
One year of laboratory-based COVID-19 surveillance system in Belgium: main indicators and performance of the laboratories (March 2020-21).
Meurisse, Marjan; Lajot, Adrien; Dupont, Yves; Lesenfants, Marie; Klamer, Sofieke; Rebolledo, Javiera; Lernout, Tinne; Leroy, Mathias; Capron, Arnaud; Van Bussel, Johan; Quoilin, Sophie; Andre, Emmanuel; Kehoe, Kaat; Waumans, Luc; Van Acker, Jos; Vandenberg, Olivier; Van den Wijngaert, Sigi; Verdonck, Ann; Cuypers, Lize; Van Cauteren, Dieter.
Affiliation
  • Meurisse M; Scientific Directorate of Epidemiology and Public Health, Service Epidemiology of infectious diseases, Sciensano, J. Wytsmanstraat 14, 1050, Brussels, Belgium. Marjan.Meurisse@sciensano.be.
  • Lajot A; Scientific Directorate of Epidemiology and Public Health, Service Epidemiology of infectious diseases, Sciensano, J. Wytsmanstraat 14, 1050, Brussels, Belgium.
  • Dupont Y; Scientific Directorate of Epidemiology and Public Health, Service Epidemiology of infectious diseases, Sciensano, J. Wytsmanstraat 14, 1050, Brussels, Belgium.
  • Lesenfants M; Scientific Directorate of Epidemiology and Public Health, Service Epidemiology of infectious diseases, Sciensano, J. Wytsmanstraat 14, 1050, Brussels, Belgium.
  • Klamer S; Scientific Directorate of Epidemiology and Public Health, Service Epidemiology of infectious diseases, Sciensano, J. Wytsmanstraat 14, 1050, Brussels, Belgium.
  • Rebolledo J; Scientific Directorate of Epidemiology and Public Health, Service Epidemiology of infectious diseases, Sciensano, J. Wytsmanstraat 14, 1050, Brussels, Belgium.
  • Lernout T; Scientific Directorate of Epidemiology and Public Health, Service Epidemiology of infectious diseases, Sciensano, J. Wytsmanstraat 14, 1050, Brussels, Belgium.
  • Leroy M; Scientific Directorate of Epidemiology and Public Health, Service Epidemiology of infectious diseases, Sciensano, J. Wytsmanstraat 14, 1050, Brussels, Belgium.
  • Capron A; Quality of Laboratories, Sciensano, J. Wytsmanstraat 14, 1050, Brussels, Belgium.
  • Van Bussel J; Healthdata.be, Sciensano, J. Wytsmanstraat 14, 1050, Brussels, Belgium.
  • Quoilin S; Scientific Directorate of Epidemiology and Public Health, Service Epidemiology of infectious diseases, Sciensano, J. Wytsmanstraat 14, 1050, Brussels, Belgium.
  • Andre E; National Reference Center Respiratory Pathogens, Department of Laboratory Medicine, UZ Leuven, Herestraat 49, 3000, Leuven, Belgium.
  • Kehoe K; Laboratory of Clinical Bacteriology and Mycology, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, 3000, Leuven, Belgium.
  • Waumans L; Department of Clinical and Molecular Pathology, AML, Sonic Healthcare, Antwerp, Belgium.
  • Van Acker J; Clinical Laboratory, Jessa Hospital, Hasselt, Belgium.
  • Vandenberg O; Laboratory of Clinical Microbiology, AZ Sint-Lucas, Groenebriel 1, 9000, Ghent, Belgium.
  • Van den Wijngaert S; Department of Microbiology, LHUB-ULB, Université Libre de Bruxelles, Brussels, Belgium.
  • Verdonck A; Center for Environmental Health and Occupational Health, School of Public Health, Université Libre de Bruxelles (ULB), Brussels, Belgium.
  • Cuypers L; Division of Infection and Immunity, Faculty of Medical Sciences, University College London, London, UK.
  • Van Cauteren D; Department of Microbiology, LHUB-ULB, Université Libre de Bruxelles, Brussels, Belgium.
Arch Public Health ; 79(1): 188, 2021 Oct 27.
Article in En | MEDLINE | ID: mdl-34706768
ABSTRACT

BACKGROUND:

With the spread of coronavirus disease 2019 (COVID-19), an existing national laboratory-based surveillance system was adapted to daily monitor the epidemiological situation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the Belgium by following the number of confirmed SARS-CoV-2 infections, the number of performed tests and the positivity ratio. We present these main indicators of the surveillance over a one-year period as well as the impact of the performance of the laboratories, regarding speed of processing the samples and reporting results, for surveillance.

METHODS:

We describe the evolution of test capacity, testing strategy and the data collection methods during the first year of the epidemic in Belgium.

RESULTS:

Between the 1st of March 2020 and the 28th of February 2021, 9,487,470 tests and 773,078 COVID-19 laboratory confirmed cases were reported. Two epidemic waves occurred, with a peak in April and October 2020. The capacity and performance of the laboratories improved continuously during 2020 resulting in a high level performance. Since the end of November 2020 90 to 95% of the test results are reported at the latest the day after sampling was performed.

CONCLUSIONS:

Thanks to the effort of all laboratories a performant exhaustive national laboratory-based surveillance system to monitor the epidemiological situation of SARS-CoV-2 was set up in Belgium in 2020. On top of expanding the number of laboratories performing diagnostics and significantly increasing the test capacity in Belgium, turnaround times between sampling and testing as well as reporting were optimized over the first year of this pandemic.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Screening_studies Language: En Journal: Arch Public Health Year: 2021 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Screening_studies Language: En Journal: Arch Public Health Year: 2021 Document type: Article Affiliation country:
...